Nuix Limited (ASX:NXL)
Australia · Delayed Price · Currency is AUD | Market Cap | 497.71M -36.0% |
| Revenue (ttm) | 237.49M +4.5% |
| Net Income | 12.27M |
| EPS | 0.03 |
| Shares Out | 335.16M |
| PE Ratio | 48.35 |
| Forward PE | 20.60 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,859,117 |
| Average Volume | 1,854,593 |
| Open | 1.500 |
| Previous Close | 1.485 |
| Day's Range | 1.490 - 1.580 |
| 52-Week Range | 1.070 - 3.350 |
| Beta | 1.87 |
| RSI | 61.25 |
| Earnings Date | Feb 22, 2026 |
About Nuix Limited
Nuix Limited provides investigative analytics and intelligence software solutions in the Asia Pacific, the Americas, Europe, the Middle East, and Africa. The company offers Nuix Neo Platform, a solution-based offering that solves most challenging data problems; Nuix Neo Data Privacy for managing data privacy; Nuix Neo Investigations, collaborates in real time and uncover the truth with insights on a massive scale; and Nuix Neo Legal provides insights from data and make decisions for law firms and legal service providers. It also provides Nuix N... [Read more]
Financial Performance
Financial StatementsNews
Nuix Limited Earnings Call Transcript: H1 2026
ACV grew 8.4% year-over-year to AUD 234.4 million, with Nuix Neo ACV up 148% and revenue up 15.2%. Adjusted management EBITDA rose 42.6%, and cash flow improved significantly. The Neo migration program and AI positioning are driving transformation and future growth.
Nuix Wins Multiyear Contract with German Tax Authority to Strengthen Investigative and Regulatory Capabilities
SYDNEY , Sept. 17, 2025 /PRNewswire/ -- Nuix ('the Company', ASX: NXL) today announces it has won a multiyear contract to supply forensic analysis software to the tax authority of German state Rhinela...
Nuix Limited Earnings Call Transcript: H2 2025
ACV grew 8% to AUD 228.4 million, led by 132% growth in Nuix Neo, while cash EBITDA rose 24.5% to AUD 37.2 million. Revenue was flat due to fewer multi-year deals, and churn increased among lower-value customers as focus shifted to larger contracts.
Nuix Limited Earnings Call Transcript: H1 2025
ACV grew 8.3% year-over-year to AUD 216.2 million, with strong subscription momentum and a 30.6% rise in cash EBITDA. Nuix Neo platform adoption is driving larger deals, and full-year ACV growth is expected in the 11%-16% range, with positive cash flow and revenue growth outpacing costs.
Nuix Limited Transcript: AGM 2024
The meeting highlighted strong FY24 financial growth, successful launch of the Nuix Neo platform, and strategic progress in innovation and market expansion. Board and executive changes were noted, and all resolutions were put to a poll with broad shareholder engagement.
Nuix Limited Earnings Call Transcript: H2 2024
FY24 saw robust growth with ACV up 14% and revenue up 20.9%, driven by the successful launch and adoption of the Nuix Neo platform. Profitability and cash flow improved significantly, and the outlook targets 15% ACV growth and continued investment in innovation.